Relmada Therapeutics market cap RLMD
Share price times shares outstanding: what the whole company sells for, since 2014.
- Today, Nov 2, 2026
- $409.6M
- Highest close in our data
- $801.4M
- May 2026
Relmada Therapeutics is worth $409.6M at the close on Nov 2, 2026, at $3.84 a share.
That is up 366% over the last year and up 346% over five years.
Its highest close in our data was $801.4M in May 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $409.6M | $260.3M | $801.4M | +24% |
| 2025 | $330.7M | $7.8M | $330.7M | +2762% |
| 2024 | $11.6M | $11M | $51.2M | −63% |
| 2023 | $31M | $17M | $35.8M | +18% |
| 2022 | $26.3M | $20.2M | $222.4M | −67% |
| 2021 | $79.1M | $59.4M | $129.1M | −24% |
| 2020 | $104.1M | $55.7M | $146.5M | +30% |
| 2019 | $80.4M | $6.7M | $88.3M | +1129% |
| 2018 | $6.5M | $1.8M | $6.8M | +247% |
| 2017 | $1.9M | $1.7M | $3M | −28% |
| 2016 | $2.6M | $1.5M | $8.4M | −55% |
| 2015 | $5.8M | $5.4M | $38.1M | −82% |
| 2014 | $32M | $8.6M | $32M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Relmada Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| RLMDRelmada Therapeutics | $409.6M |
| CRMDCorMedix | $420.1M |
| ARVNArvinas | $491.7M |
| PBYIPuma Biotechnology | $525.5M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $599.8M |
| COLLCollegium Pharmaceutical | $770.9M |
| ABUSArbutus Biopharma | $791.4M |
| NATRNatures Sunshine Products | $211.5M |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| OMEROmeros | $1.3B |
| Peer median | $585.8M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Relmada Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.